666
C. Ding, K. Maruoka
CLUSTER
(5) (a) Ooi, T.; Takeuchi, M.; Kameda, M.; Maruoka, K. J. Am.
Chem. Soc. 2000, 122, 5228. (b) Ooi, T.; Kameda, M.;
Tannai, H.; Maruoka, K. Tetrahedron Lett. 2000, 41, 8339.
(c) Ooi, T.; Takeuchi, M.; Maruoka, K. Synthesis 2001,
1716. (d) Ooi, T.; Kameda, M.; Maruoka, K. J. Am. Chem.
Soc. 2003, 125, 5139. (e) Ooi, T.; Uematsu, Y.; Maruoka, K.
Tetrahedron Lett. 2004, 45, 1675. (f) Ooi, T.; Kameda, M.;
Fujii, J.-i.; Maruoka, K. Org. Lett. 2004, 6, 2397. (g) Jew,
S.-s.; Lee, Y.-J.; Lee, J.; Kang, M. J.; Jeong, B.-S.; Lee,
J.-H.; Yoo, M.-S.; Kim, M.-J.; Choi, S.-h.; Ku, J.-M.; Park,
H.-g. Angew. Chem. Int. Ed. 2004, 43, 2382. (h) Maeda, K.;
Miller, R. A.; Szumigala, R. H. Jr.; Shafiee, A.; Karady, S.;
Armstrong, J. D. III Tetrahedron Lett. 2005, 46, 1545.
(i) Lee, Y.-J.; Lee, J.; Kim, M.-J.; Jeong, B.-S.; Lee, J.-H.;
Kim, T.-S.; Lee, J.; Ku, J.-M.; Jew, S.-s.; Park, H.-g. Org.
Lett. 2005, 7, 3207. (j) Kim, T.-S.; Lee, Y.-J.; Jeong, B.-S.;
Park, H.-g.; Jew, S.-s. J. Org. Chem. 2006, 71, 8276.
(6) (a) Ooi, T.; Miki, T.; Taniguchi, M.; Shiraishi, M.; Takeuchi,
M.; Maruoka, K. Angew. Chem. Int. Ed. 2003, 42, 3796.
(b) Ooi, T.; Miki, T.; Maruoka, K. Org. Lett. 2005, 7, 191.
(c) Ooi, T.; Miki, T.; Fukumoto, K.; Maruoka, K. Adv. Synth.
Catal. 2006, 348, 1539.
(7) Typical Procedure for the Catalytic Asymmetric
Alkylation of tert-Butyl 2-Fluoro-3-oxo-3-phenyl-
propanoate (2b) under Phase-Transfer Conditions
To a solution of phase-transfer catalyst (S,S)-1 (0.001 mmol,
0.9 mg) and 2b (0.10 mmol, 23.6 mg) in mesitylene (2 mL)
was added benzyl bromide (0.12 mmol, 14.0 mL), and the
mixture was cooled to 0 °C. After adding 10% aq CsOH (0.3
mL, ca. 0.2 mmol) to this mixture, the reaction mixture was
vigorously stirred until the completion of the reaction. The
mixture was then poured into sat. aq NH4Cl and extracted
with EtOAc. The organic layer was dried over Na2SO4 and
concentrated in vacuo. The residue was purified by column
chromatography on SiO2 to give tert-butyl 2-benzyl-2-
fluoro-3-oxo-3-phenylpropanoate (3b) as a colorless oil
[82% (26.8 mg), 85% ee]. Enantiomeric purity was
References and Notes
(1) For general reviews, see: (a) Mann, J. Chem. Soc. Rev.
1987, 16, 381. (b) Welch, J. T. Tetrahedron 1987, 43, 3123.
(c) Welch, J. T. Selective Fluorination, ACS Symposium
Series 456; American Chemical Society: Washington DC,
1991. (d) Wilkinson, J. A. Chem. Rev. 1992, 92, 505.
(e) Filler, R.; Kobayashi, Y.; Yagupolskii, Y. L.
Organofluorine Compounds in Medicinal Chemistry and
Biological Applications; Elsevier: Amsterdam, 1993.
(f) Banks, R. E.; Smart, B. E.; Tatlow, J. C. Organofluorine
Chemistry: Principles and Commercial Applications;
Plenum Press: New York, 1994. (g) Hudlicky, M.; Pavlath,
A. E. Chemistry of Organic Fluorine Compounds II. A
Critical Review, ACS Monograph 187; American Chemical
Society: Washington DC, 1995. (h) Biomedical Frontiers of
Fluorine Chemistry; Ojima, I.; McCarthy, J. R.; Welch, J. T.,
Eds.; American Chemical Society: Washington DC, 1996.
(i) Organofluorine Compounds. Chemistry and
Applications; Hiyama, T., Ed.; Springer: New York, 2000.
(2) (a) Bravo, P.; Resnati, G. Tetrahedron: Asymmetry 1990, 1,
661. (b) Resnati, G. Tetrahedron 1993, 49, 9385.
(c) Hayashi T., Soloshonok V. A., Eds. Tetrahedron:
Asymmetry 1994, 5, 955. (d)Iseki, K. Tetrahedron1998, 54,
13887. (e) Soloshonok, V. A. Enantiocontrolled Synthesis of
Fluoro-Organic Compounds; Wiley: Chichester, 1999.
(f) Asymmetric Fluoroorganic Chemistry. Synthesis,
Applications, and Future Directions, ACS Symposium
Series 746; Ramachandran, P. V., Ed.; American Chemical
Society: Washington DC, 2000.
(3) (a) Ma, J.-A.; Cahard, D. Chem. Rev. 2004, 104, 6119.
(b) Pihko, P. M. Angew. Chem. Int. Ed. 2006, 45, 544.
(c) Prakash, G. K.; Beier, S. P. Angew. Chem. Int. Ed. 2006,
45, 2172. (d) Bobbio, C.; Gouverneur, V. Org. Biomol.
Chem. 2006, 4, 2065. (e) Shibata, N.; Ishimaru, T.;
Nakamura, S.; Toru, T. J. Fluorine Chem. 2007, 128, 469.
(f) Brunet, V. A.; O’Hagan, D. Angew. Chem. Int. Ed. 2008,
47, 1179; and references cited therein . See also:
determined by HPLC analysis [Daicel Chiralpak OD,
hexane–2-PrOH (300:1), flow rate = 0.5 mL/min, 254 nm,
tR = 18.8 min(minor) and 21.7 min(major)]. 1H NMR (400
MHz, CDCl3): d = 7.99–8.02 (2 H, m, ArH), 7.53–7.58 (1 H,
m, ArH), 7.41–7.44 (2 H, m, ArH), 7.25–7.30 (5 H, m, ArH),
3.46–3.68 (2 H, m, PhCH2), 1.29 (9 H, s, t-Bu).
(g) Hamashima, Y.; Yagi, K.; Takano, H.; Tamás, L.;
Sodeoka, M. J. Am. Chem. Soc. 2002, 124, 14530. (h) Kim,
D. Y.; Park, E. J. Org. Lett. 2002, 4, 545.
(4) For recent reviews, see: (a) Hashimoto, T.; Maruoka, K.
Chem. Rev. 2007, 107, 5656. (b) Ooi, T.; Maruoka, K.
Angew. Chem. Int. Ed. 2007, 46, 4222. (c) Ooi, T.;
Maruoka, K. Aldrichimica Acta 2007, 40, 77. (d) Maruoka,
K.; Ooi, T.; Kano, T. Chem. Commun. 2007, 1487.
Synlett 2009, No. 4, 664–666 © Thieme Stuttgart · New York